SCHEMBL9920792

SCHEMBL9920792

Cc1ccc(-c2ccc3ccc4c(-c5ccc(C)cc5)cc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)c5ccc2c3c45)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
RXFP1 Q9HBX9 3/20 0.34
FLT3 P36888 1/20 0.32
MAPT P10636 2/20 0.32
COMT P21964 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MCL1 Q07820 1/20 0.31
BAD Q92934 1/20 0.31
TP53 P04637 2/20 0.31
AKR1C4 P17516 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
AKR1C1 Q04828 1/20 0.31
CCNA2 P20248 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920736 0.96 L3MBTL1 (0.38) ALDH1A1LMNAGAAL3MBTL1KDM4E
SCHEMBL9920641 0.93 ALDH1A1 (0.36) ALDH1A1LMNAGAAL3MBTL1KDM4E
SCHEMBL9920964 0.92 L3MBTL1 (0.44) ALDH1A1GAAL3MBTL1KDM4EATM
SCHEMBL9920790 0.92 L3MBTL1 (0.44) ALDH1A1GAAL3MBTL1KDM4EATM
SCHEMBL9939617 0.92 L3MBTL1 (0.42) ALDH1A1GAAL3MBTL1KDM4EATM
SCHEMBL9920635 0.90 L3MBTL1 (0.39) ALDH1A1LMNAL3MBTL1KDM4EATM
SCHEMBL9920921 0.88 KDM4E (0.37) ALDH1A1L3MBTL1KDM4EATMHSD17B10
SCHEMBL9920727 0.88 L3MBTL1 (0.45) ALDH1A1GAAL3MBTL1KDM4EATM
SCHEMBL9921063 0.88 L3MBTL1 (0.45) ALDH1A1GAAL3MBTL1KDM4EATM
SCHEMBL9920789 0.88 ALDH1A1 (0.37) ALDH1A1LMNAL3MBTL1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
EP-1942171-B1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES (JP) 2018-04-18 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20110121268-A1 LIGHT-EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2011-05-26 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 ALDH1A1 1929/4885LMNA 1946/4885GAA 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.